• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病样慢性移植物抗宿主病后伴部分脂肪营养不良的糖尿病

Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease.

作者信息

Rooney D P, Ryan M F

机构信息

Department of Diabetes and Endocrinology and Biochemistry Laboratory, Antrim Area Hospital, Antrim, UK.

出版信息

Diabet Med. 2006 Apr;23(4):436-40. doi: 10.1111/j.1464-5491.2006.01855.x.

DOI:10.1111/j.1464-5491.2006.01855.x
PMID:16620274
Abstract

BACKGROUND

The importance of adipose tissue in metabolism, as a target for insulin action and a secretor of metabolic regulatory proteins, is increasingly recognized. Lipodystrophic conditions are often associated with significant insulin resistance. The commonest acquired form occurs with highly active antiretroviral therapy (HAART) for human immunodeficiency virus infection. Other medical conditions and drugs also have the potential to cause chronic subcutaneous fat damage.

CASE REPORT

We describe an unfamiliar partial lipodystrophy in a young woman, associated with markedly insulin-resistant diabetes, acquired following allogeneic bone marrow transplantation for childhood leukaemia complicated by late sclerodermatous chronic graft vs. host disease (GVHD). Clinical examination revealed scarring and lipodystrophy affecting mainly legs, thighs, buttocks and forearms but sparing her face, neck and thorax. Her serum adiponectin level was markedly reduced.

CONCLUSIONS

However, although thiazolidinediones lower insulin resistance and increase subcutaneous peripheral fat in Type 2 diabetes, pioglitazone treatment had little effect on either serum adiponectin, glycaemic control or the lipoatrophy. In this case, effective glycaemic control was best achieved using a combination of metformin and highly concentrated soluble insulin injections.

摘要

背景

脂肪组织在新陈代谢中的重要性日益得到认可,它是胰岛素作用的靶点以及代谢调节蛋白的分泌者。脂肪营养不良症常与显著的胰岛素抵抗相关。最常见的后天性形式发生在用于治疗人类免疫缺陷病毒感染的高效抗逆转录病毒疗法(HAART)中。其他病症和药物也有可能导致慢性皮下脂肪损害。

病例报告

我们描述了一名年轻女性中一种不常见的部分脂肪营养不良症,其与显著的胰岛素抵抗性糖尿病相关,该病症是在因儿童白血病接受异基因骨髓移植并伴有晚期硬皮病样慢性移植物抗宿主病(GVHD)后出现的。临床检查发现瘢痕形成和脂肪营养不良,主要影响腿部、大腿、臀部和前臂,但面部、颈部和胸部未受影响。她的血清脂联素水平显著降低。

结论

然而,尽管噻唑烷二酮类药物可降低2型糖尿病患者的胰岛素抵抗并增加皮下外周脂肪,但吡格列酮治疗对血清脂联素、血糖控制或脂肪萎缩几乎没有影响。在该病例中,使用二甲双胍和高浓度可溶性胰岛素注射联合治疗可最佳地实现有效的血糖控制。

相似文献

1
Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease.硬皮病样慢性移植物抗宿主病后伴部分脂肪营养不良的糖尿病
Diabet Med. 2006 Apr;23(4):436-40. doi: 10.1111/j.1464-5491.2006.01855.x.
2
Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.吡格列酮和二甲双胍对2型糖尿病患者肝脏和骨骼肌细胞内脂质含量的影响。
Metabolism. 2007 Oct;56(10):1418-24. doi: 10.1016/j.metabol.2007.06.005.
3
Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.吡格列酮对一名患有与邓尼根综合征相关糖尿病女性患者代谢控制的长期改善:病例报告
Diabetes Metab. 2009 Apr;35(2):151-4. doi: 10.1016/j.diabet.2009.01.001. Epub 2009 Feb 26.
4
Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.吡格列酮和二甲双胍对新诊断2型糖尿病患者血浆脂联素的影响
Clin Endocrinol (Oxf). 2006 Dec;65(6):722-8. doi: 10.1111/j.1365-2265.2006.02658.x.
5
Metformin and pioglitazone: Effectively treating insulin resistance.二甲双胍和吡格列酮:有效治疗胰岛素抵抗。
Curr Med Res Opin. 2006;22 Suppl 2:S27-37. doi: 10.1185/030079906X112732.
6
Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease.与慢性移植物抗宿主病相关的获得性部分脂肪营养不良中胰岛素需求的暂时缓解。
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26427. Epub 2017 Mar 29.
7
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.格列美脲与吡格列酮联合治疗对二甲双胍单药治疗控制不佳的2型糖尿病患者的疗效:一项随机临床试验的结果
Curr Med Res Opin. 2006 Apr;22(4):751-9. doi: 10.1185/030079906X104786.
8
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.HIV脂肪代谢障碍及其代谢后果:对临床实践的影响。
Curr Med Res Opin. 2008 Mar;24(3):609-24. doi: 10.1185/030079908X272742.
9
Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.硬皮病样慢性移植物抗宿主病——4例儿科病例报告
Pediatr Dermatol. 2008 Mar-Apr;25(2):240-4. doi: 10.1111/j.1525-1470.2008.00643.x.
10
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.吡格列酮与二甲双胍对2型糖尿病患者肝脏及肝外胰岛素作用影响的比较
Diabetes. 2008 Jan;57(1):24-31. doi: 10.2337/db07-0827. Epub 2007 Oct 3.

引用本文的文献

1
Longitudinal proteomics study of serum changes after allogeneic HSCT reveals potential markers of metabolic complications related to aGvHD.异基因 HSCT 后血清变化的纵向蛋白质组学研究揭示了与 aGvHD 相关代谢并发症的潜在标志物。
Sci Rep. 2022 Aug 17;12(1):14002. doi: 10.1038/s41598-022-18221-9.
2
Approach to the Patient With Lipodystrophy.脂代谢障碍患者处理方法。
J Clin Endocrinol Metab. 2022 May 17;107(6):1714-1726. doi: 10.1210/clinem/dgac079.
3
Lipodystrophy as a Late Effect after Stem Cell Transplantation.脂肪营养不良作为干细胞移植后的晚期效应。
J Clin Med. 2021 Apr 8;10(8):1559. doi: 10.3390/jcm10081559.
4
Body composition after allogeneic haematopoietic cell transplantation/total body irradiation in children and young people: a restricted systematic review.异基因造血细胞移植/全身照射后儿童和青少年的身体成分:一项有条件的系统评价。
J Cancer Surviv. 2020 Oct;14(5):624-642. doi: 10.1007/s11764-020-00871-1. Epub 2020 Jul 18.
5
Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People.儿童和青少年脂肪营养不良综合征管理中的当前诊断、治疗及临床挑战
J Clin Res Pediatr Endocrinol. 2020 Mar 19;12(1):17-28. doi: 10.4274/jcrpe.galenos.2019.2019.0124. Epub 2019 Aug 22.
6
Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.获得性部分脂肪萎缩作为移植物抗宿主病及米替福辛治疗:两例报告
J Med Case Rep. 2018 Dec 14;12(1):368. doi: 10.1186/s13256-018-1901-y.
7
Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list.儿童期骨髓移植后获得性部分脂肪营养不良:一种需添加到疾病分类列表中的新型综合征。
J Endocrinol Invest. 2017 Nov;40(11):1273-1274. doi: 10.1007/s40618-017-0731-x. Epub 2017 Jul 18.
8
Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.儿童期接受造血干细胞移植患者的部分脂肪营养不良:一项机构横断面调查。
Clin Pediatr Endocrinol. 2017;26(2):99-108. doi: 10.1297/cpe.26.99. Epub 2017 Apr 22.
9
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后内分泌代谢功能障碍的管理
Orphanet J Rare Dis. 2014 Oct 29;9:162. doi: 10.1186/s13023-014-0162-0.
10
Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy.造血干细胞移植后五名儿童出现脂肪组织分布异常且代谢状况不佳:获得性部分脂肪营养不良的新病因。
Clin Pediatr Endocrinol. 2013 Oct;22(4):53-64. doi: 10.1292/cpe.22.53. Epub 2013 Oct 26.